Two Sigma Securities’s Fulgent Genetics FLGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-14,500
Closed -$388K 3201
2023
Q3
$388K Buy
+14,500
New +$495K ﹤0.01% 1728
2022
Q4
Sell
-17,800
Closed -$679K 2783
2022
Q3
$679K Buy
17,800
+4,800
+37% +$241K 0.02% 863
2022
Q2
$709K Buy
13,000
+7,200
+124% +$396K 0.03% 705
2022
Q1
$362K Buy
+5,800
New +$382K 0.01% 1243

Other funds holding FLGT

Two Sigma Securities's FLGT Position: Q1 2023 in Review

Two Sigma Securities sold out of Fulgent Genetics (FLGT) in Q1 2023, closing a stake of 7,387 shares — an estimated $238K sold.

Two Sigma Securities first reported a position in FLGT in Q4 2022 and held it in 1 quarter. The position peaked at $220K in Q4 2022. 215 funds tracked by Wall St. Rank hold FLGT as of Q1 2023.

  • Two Sigma Securities reported no remaining Fulgent Genetics position as of Q1 2023 after selling out during the quarter.
  • Two Sigma Securities sold 7,387 Fulgent Genetics shares in Q1 2023, an estimated $238K.
  • Two Sigma Securities first reported a position in Fulgent Genetics in Q4 2022 and held it in 1 quarter.
  • Two Sigma Securities's Fulgent Genetics position peaked at $220K in Q4 2022.
  • 215 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2023.

Based on Two Sigma Securities's 13F filing for Q1 2023, filed 15 May 2023.